학술논문
Treatment of acute hepatitis C genotypes 1 and 4 with 8 weeks of grazoprevir plus elbasvir (DAHHS2): an open-label, multicentre, single-arm, phase 3b trial
Document Type
Article
Author
Boerekamps, Anne; De Weggheleire, Anja; van den Berk, Guido E; Lauw, Fanny N; Claassen, Mark A A; Posthouwer, Dirk; Bierman, Wouter F; Hullegie, Sebastiaan J; Popping, Stephanie; van de Vijver, David A C M; Dofferhoff, Anthonius S M; Kootstra, Gert Jan; Leyten, Eliane M; den Hollander, Jan; van Kasteren, Marjo E; Soetekouw, Robert; Ammerlaan, Heidi S M; Schinkel, Janke; Florence, Eric; Arends, Joop E; Rijnders, Bart J A
Source
In The Lancet Gastroenterology & Hepatology April 2019 4(4):269-277
Subject
Language
ISSN
2468-1253